Dimitrios Drekolias, MD
Assistant Professor of Medicine, Division of Hematology and Oncology
Hematologist and Medical Oncologist, University of Vermont Health
Given E217
89 Beaumont Ave
Larner College of Medicine
Burlington, VT 05405
United States
- MD, National and Kapodistrian University of Athens, Medical School
Department of Medicine, Division of Hematology and Oncology
Hematology and Oncology, University of Vermont Medical Center - Main Campus
Hematology and Oncology, University of Vermont Health - Central Vermont Medical Center
Area(s) of expertise
- Thrombosis and Hemostasis
- Bleeding Disorders
- Disorders of Iron Metabolism
- Classical Hematology
BIO
Dr. Dimitrios Drekolias is an Assistant Professor of Medicine at the University of Vermont Larner College of Medicine and an Attending Physician in Hematology/Oncology at UVM Health. He completed his Internal Medicine Residency training at the University of Connecticut (Farmington, CT) and his Hematology/Oncology Fellowship at the University of South Florida – H. Lee Moffitt Cancer Center and Research Institute (Tampa, FL). His clinical area of focus is Classical Hematology.
Dr. Drekolias' postdoctoral training
- Fellowship in Hematology and Medical Oncology, H.Lee Moffitt Cancer Center and Research Institute, University of South Florida. Tampa, FL
- Internal Medicine Residency, University of Connecticut - Farmington, CT
Dr. Drekolias' Professional Societies and Memberships
- American Society of Hematology
- American Society of Clinical Oncology
Dr. Drekolias' recent publications
- Case of KRAS G12C-Mutated AML Treated With Sotorasib - https://pubmed.ncbi.nlm.nih.gov/40712108/
- Antiphospholipid Syndrome (book chapter) - https://link.springer.com/chapter/10.1007/978-3-031-62373-8_38
- High-risk Myelodysplastic Syndrome (HR-MDS) Treated with a Hypomethylating Agent (HMA) and Venetoclax – Focus on Antifungal (AF) Prophylaxis and Molecular Subset Outcomes - https://www.sciencedirect.com/science/article/pii/S0006497124045907
- Activity and Safety of Venetoclax (VEN)-Based Treatment in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (R/R MM) - https://www.sciencedirect.com/science/article/pii/S0006497124074986
- Association of Venetoclax-based Therapy with Increased Survival in Multiple Myeloma (MM) Harboring t(11;14): A Single-center Experience - https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.e20055
- Hematopoietic Recovery after Anti-B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T Cell Therapy (CAR T), Idecabtagene Vicleucel (Ide-cel), for Relapsed/Refractory Multiple Myeloma (RRMM) - https://tandem.confex.com/tandem/2023/meetingapp.cgi/Paper/22081
- Visual Loss Treated with Osimertinib: A Case Report - https://www.sciencedirect.com/science/article/pii/S2666621922000011
- Anticoagulant-Related Nephropathy: A Common, Under-Diagnosed Clinical Entity - https://pubmed.ncbi.nlm.nih.gov/35340514/
Paraneoplastic Confusion: A Case of Anti-Hu Encephalitis - https://pubmed.ncbi.nlm.nih.gov/32821559/
Courses
- PCR: Professionalism, Communication, and Reflection
Publications
Dr. Drekolias's publications on PubMed
Awards and Achievements
- Maxwell O. Phelps M.D. Award for Outstanding Scholarship during Internal Medicine Residency at the University of Connecticut (June 2022).
Bio
Dr. Dimitrios Drekolias is an Assistant Professor of Medicine at the University of Vermont Larner College of Medicine and an Attending Physician in Hematology/Oncology at UVM Health. He completed his Internal Medicine Residency training at the University of Connecticut (Farmington, CT) and his Hematology/Oncology Fellowship at the University of South Florida – H. Lee Moffitt Cancer Center and Research Institute (Tampa, FL). His clinical area of focus is Classical Hematology.
Dr. Drekolias' postdoctoral training
- Fellowship in Hematology and Medical Oncology, H.Lee Moffitt Cancer Center and Research Institute, University of South Florida. Tampa, FL
- Internal Medicine Residency, University of Connecticut - Farmington, CT
Dr. Drekolias' Professional Societies and Memberships
- American Society of Hematology
- American Society of Clinical Oncology
Dr. Drekolias' recent publications
- Case of KRAS G12C-Mutated AML Treated With Sotorasib - https://pubmed.ncbi.nlm.nih.gov/40712108/
- Antiphospholipid Syndrome (book chapter) - https://link.springer.com/chapter/10.1007/978-3-031-62373-8_38
- High-risk Myelodysplastic Syndrome (HR-MDS) Treated with a Hypomethylating Agent (HMA) and Venetoclax – Focus on Antifungal (AF) Prophylaxis and Molecular Subset Outcomes - https://www.sciencedirect.com/science/article/pii/S0006497124045907
- Activity and Safety of Venetoclax (VEN)-Based Treatment in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (R/R MM) - https://www.sciencedirect.com/science/article/pii/S0006497124074986
- Association of Venetoclax-based Therapy with Increased Survival in Multiple Myeloma (MM) Harboring t(11;14): A Single-center Experience - https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.e20055
- Hematopoietic Recovery after Anti-B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T Cell Therapy (CAR T), Idecabtagene Vicleucel (Ide-cel), for Relapsed/Refractory Multiple Myeloma (RRMM) - https://tandem.confex.com/tandem/2023/meetingapp.cgi/Paper/22081
- Visual Loss Treated with Osimertinib: A Case Report - https://www.sciencedirect.com/science/article/pii/S2666621922000011
- Anticoagulant-Related Nephropathy: A Common, Under-Diagnosed Clinical Entity - https://pubmed.ncbi.nlm.nih.gov/35340514/
Paraneoplastic Confusion: A Case of Anti-Hu Encephalitis - https://pubmed.ncbi.nlm.nih.gov/32821559/
Courses
- PCR: Professionalism, Communication, and Reflection
Publications
Awards and Achievements
- Maxwell O. Phelps M.D. Award for Outstanding Scholarship during Internal Medicine Residency at the University of Connecticut (June 2022).